Abstract
The advent of routinely available genomics and sequencing of the human genome, among others, associated with advances in technology previously limited to biochemical research, and in bioinformatics has brought the new field of proteomics within the reach of the life sciences and even clinical research. Important hypotheses are increasingly being generated in lung disease by biomarker identification from screening of clinical samples. However, proteomics, ideally suited for biomarker discovery, is only just emerging as a field of research in intensive care and has, to date, mostly been applied to serumin studies of sepsis [1–5]. The purpose of this chapter is to overview the rationale, basics, methods, pitfalls, applications, and future directions for lung proteomics in intensive care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Buhimschi CS, Bhandari V, Hamar BD, et al (2007) Proteomic profiling of the amniotic fluid to detect inflammation, infection, and neonatal sepsis. PLoS Med 4:e18
Crouser ED, Julian MW, Huff JE, Mandich DV, Green-Church KB (2006) A proteomic analysis of liver mitochondria during acute endotoxemia. Intensive Care Med 32: 1252–1262
Holly MK, Dear JW, Hu X, et al (2006) Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 70: 496–506
Kalenka A, Feldmann RE Jr, Otero K, Maurer MH, Waschke KF, Fiedler F (2006) Changes in the serum proteome of patients with sepsis and septic shock. Anesth Analg 103: 1522–1526
Ren Y, Wang J, Xia J, et al (2007) The alterations of mouse plasma proteins during septic development. J Proteome Res 6: 2812–2821
Manolio T (2003) Novel risk markers and clinical practice. N Engl J Med 349: 1587–1589
Ackland GL, Mythen MG (2007) Novel biomarkers in critical care: utility or futility? Crit Care 11:175
Becker KL, Snider R, Nylen ES (2008) Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med 36: 941–952
McLean AS, Huang SJ, Hyams S, et al (2007) Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 35: 1019–1026
Garcia JG, Moreno Vinasco L (2006) Genomic insights into acute inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol 291:L1113–1117
Meyer NJ, Garcia JG (2007) Wading into the genomic pool to unravel acute lung injury genetics. Proc Am Thorac Soc 4: 69–76
Nonas SA, Finigan JH, Gao L, Garcia JG (2005) Functional genomic insights into acute lung injury: role of ventilators and mechanical stress. Proc Am Thorac Soc 2: 188–194
Poly WJ (1997) Nongenetic variation, genetic-environmental interactions and altered gene expression. III. Posttranslational modifications. Comp Biochem Physiol A Physiol 118: 551–572
Gygi SP, Rochon Y, Franza BR, Aebersold R (1999) Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 19: 1720–1730
Witze ES, Old WM, Resing KA, Ahn NG (2007) Mapping protein post-translational modifications with mass spectrometry. Nat Methods 4: 798–806
Bowler RP, Ellison MC, Reisdorph N (2006) Proteomics in pulmonary medicine. Chest 130: 567–574
Hirsch J, Hansen KC, Burlingame AL, Matthay MA (2004) Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 287:L1–23
Sandra K, Moshir M, D’Hondt F, Verleysen K, Kas K, Sandra P (2008) Highly efficient peptide separations in proteomics Part 1. Unidimensional high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci 866: 48–63
Jiang X, Ye M, Zou H (2008) Technologies and methods for sample pretreatment in efficient proteome and peptidome analysis. Proteomics 8: 686–705
Bowler RP, Duda B, Chan ED, et al (2004) Proteomic analysis of pulmonary edema fluid and plasma in patients with acute lung injury. Am J Physiol Lung Cell Mol Physiol 286: L1095–1104
Feng NH, Hacker A, Effros RM (1992) Solute exchange between the plasma and epithelial lining fluid of rat lungs. J Appl Physiol 72: 1081–1089
Plymoth A, Lofdahl CG, Ekberg-Jansson A, et al (2003) Human bronchoalveolar lavage: biofluid analysis with special emphasis on sample preparation. Proteomics 3: 962–972
Diamandis EP (2004) Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. J Natl Cancer Inst 96: 353–356
Garber K (2004) Debate rages over proteomic patterns. J Natl Cancer Inst 96: 816–818
Zhang Z, Chan DW (2005) Cancer proteomics: in pursuit of “true” biomarker discovery. Cancer Epidemiol Biomarkers Prev 14: 2283–2286
Domon B, Aebersold R (2006) Challenges and opportunities in proteomics data analysis. Mol Cell Proteomics 5: 1921–1926
Nesvizhskii AI, Aebersold R (2005) Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics 4: 1419–1440
Candiano G, Bruschi M, Pedemonte N, et al. (2007) Proteomic analysis of the airway surface liquid: modulation by proinflammatory cytokines. Am J Physiol Lung Cell Mol Physiol 292:L185–198
Signor L, Tigani B, Beckmann N, Falchetto R, Stoeckli M (2004) Two-dimensional electrophoresis protein profiling and identification in rat bronchoalveolar lavage fluid following allergen and endotoxin challenge. Proteomics 4: 2101–2110
Hirsch J, Niemann CU, Hansen KC, et al (2008) Alterations in the proteome of pulmonary alveolar type II cells in the rat after hepatic ischemia-reperfusion. Crit Care Med 36: 1846–1854
Schnapp LM, Donohoe S, Chen J, et al (2006) Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol 169: 86–95
Gray RD, MacGregor G, Noble D, et al (2008) Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med 178: 444–452
de Torre C, Ying SX, Munson PJ, Meduri GU, Suffredini AF (2006) Proteomic analysis of inflammatory biomarkers in bronchoalveolar lavage. Proteomics 6: 3949–3957
Bozinovski S, Cross M, Vlahos R, et al (2005) S100A8 chemotactic protein is abundantly increased, but only a minor contributor to LPS-induced, steroid resistant neutrophilic lung inflammation in vivo. J Proteome Res 4: 136–145
Chang DW, Hayashi S, Gharib SA, et al (2008) Proteomic and computational analysis of bronchoalveolar proteins during the course of the acute respiratory distress syndrome. Am J Respir Crit Care Med 178: 701–709
Ishizaka A, Watanabe M, Yamashita T, et al (2001) New bronchoscopic microsample probe to measure the biochemical constituents in epithelial lining fluid of patients with acute respiratory distress syndrome. Crit Care Med 29: 896–898
Kipnis E, Hansen K, Sawa T, et al (2008) Proteomic analysis of undiluted lung epithelial lining fluid. Chest 134: 338–345
Dudek SM, Garcia JG (2001) Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 91: 1487–1500
Gessner C, Hammerschmidt S, Kuhn H, et al (2003) Exhaled breath condensate nitrite and its relation to tidal volume in acute lung injury. Chest 124: 1046–1052
Sack U, Scheibe R, Wotzel M, et al (2006) Multiplex analysis of cytokines in exhaled breath condensate. Cytometry A 69: 169–172
Walsh BK, Mackey DJ, Pajewski T, Yu Y, Gaston BM, Hunt JF (2006) Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients. Respir Care 51: 1125–1131
Griese M, Noss J, von Bredow C (2002) Protein pattern of exhaled breath condensate and saliva. Proteomics 2: 690–696
Gessner C, Dihazi H, Brettschneider S, et al (2008) Presence of cytokeratins in exhaled breath condensate of mechanical ventilated patients. Respir Med 102: 299–306
Clermont G (2007) Modeling longitudinal data in acute illness. Crit Care 11:152
Nick JA, Coldren CD, Geraci MW, et al (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 104: 3878–3885
Li SQ, Qi HW, Wu CG, et al (2007) Comparative proteomic study of acute pulmonary embolism in a rat model. Proteomics 7: 2287–2299
Ventura CL, Higdon R, Kolker E, Skerrett SJ, Rubens CE (2008) Host airway proteins interact with Staphylococcus aureus during early pneumonia. Infect Immun 76: 888–898
Nelsestuen GL, Martinez MB, Hertz MI, Savik K, Wendt CH (2005) Proteomic identification of human neutrophil alpha-defensins in chronic lung allograft rejection. Proteomics 5: 1705–1713
Yip TT, Cho WC, Cheng WW, et al (2007) Application of ProteinChip array profiling in serum biomarker discovery for patients suffering from severe acute respiratory syndrome. Methods Mol Biol 382: 313–331
Malmstrom J, Lee H, Aebersold R (2007) Advances in proteomic workflows for systems biology. Curr Opin Biotechnol 18: 378–384
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kipnis, E., Hansen, K. (2009). Lung Proteomics in Intensive Care. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92278-2_3
Download citation
DOI: https://doi.org/10.1007/978-0-387-92278-2_3
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-92277-5
Online ISBN: 978-0-387-92278-2
eBook Packages: MedicineMedicine (R0)